rs370616172

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_006767.4(LZTR1):​c.-11G>A variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00134 in 1,546,152 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00096 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0014 ( 2 hom. )

Consequence

LZTR1
NM_006767.4 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.409

Publications

0 publications found
Variant links:
Genes affected
LZTR1 (HGNC:6742): (leucine zipper like post translational regulator 1) This gene encodes a member of the BTB-kelch superfamily. Initially described as a putative transcriptional regulator based on weak homology to members of the basic leucine zipper-like family, the encoded protein subsequently has been shown to localize exclusively to the Golgi network where it may help stabilize the Gogli complex. Deletion of this gene may be associated with DiGeorge syndrome. [provided by RefSeq, Jul 2008]
LZTR1 Gene-Disease associations (from GenCC):
  • LZTR1-related schwannomatosis
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Noonan syndrome 10
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • schwannomatosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Noonan syndrome
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Noonan syndrome 2
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: MODERATE Submitted by: G2P
  • Costello syndrome
    Inheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome with multiple lentigines
    Inheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen
  • cardiofaciocutaneous syndrome
    Inheritance: AR, AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome-like disorder with loose anagen hair
    Inheritance: AR, AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 22-20982361-G-A is Benign according to our data. Variant chr22-20982361-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 389662.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006767.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LZTR1
NM_006767.4
MANE Select
c.-11G>A
5_prime_UTR_premature_start_codon_gain
Exon 1 of 21NP_006758.2
LZTR1
NM_006767.4
MANE Select
c.-11G>A
5_prime_UTR
Exon 1 of 21NP_006758.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LZTR1
ENST00000646124.2
MANE Select
c.-11G>A
5_prime_UTR_premature_start_codon_gain
Exon 1 of 21ENSP00000496779.1Q8N653
LZTR1
ENST00000646124.2
MANE Select
c.-11G>A
5_prime_UTR
Exon 1 of 21ENSP00000496779.1Q8N653
LZTR1
ENST00000888029.1
c.-11G>A
5_prime_UTR_premature_start_codon_gain
Exon 1 of 21ENSP00000558088.1

Frequencies

GnomAD3 genomes
AF:
0.000965
AC:
147
AN:
152262
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000265
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.00184
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000913
AC:
134
AN:
146760
AF XY:
0.000911
show subpopulations
Gnomad AFR exome
AF:
0.000139
Gnomad AMR exome
AF:
0.000815
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000345
Gnomad NFE exome
AF:
0.00183
Gnomad OTH exome
AF:
0.00191
GnomAD4 exome
AF:
0.00138
AC:
1925
AN:
1393772
Hom.:
2
Cov.:
32
AF XY:
0.00133
AC XY:
911
AN XY:
687012
show subpopulations
African (AFR)
AF:
0.000190
AC:
6
AN:
31554
American (AMR)
AF:
0.000844
AC:
30
AN:
35548
Ashkenazi Jewish (ASJ)
AF:
0.0000801
AC:
2
AN:
24982
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35746
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79290
European-Finnish (FIN)
AF:
0.000508
AC:
24
AN:
47202
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5568
European-Non Finnish (NFE)
AF:
0.00168
AC:
1813
AN:
1076146
Other (OTH)
AF:
0.000866
AC:
50
AN:
57736
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
98
197
295
394
492
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000965
AC:
147
AN:
152380
Hom.:
0
Cov.:
33
AF XY:
0.000993
AC XY:
74
AN XY:
74516
show subpopulations
African (AFR)
AF:
0.000264
AC:
11
AN:
41594
American (AMR)
AF:
0.000131
AC:
2
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10630
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.00184
AC:
125
AN:
68036
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000647
Hom.:
0
Bravo
AF:
0.00103
Asia WGS
AF:
0.000289
AC:
1
AN:
3476

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
18
DANN
Benign
0.92
PhyloP100
0.41
PromoterAI
0.13
Neutral
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.1
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs370616172; hg19: chr22-21336650; API